Nasdaq smmt.

Cambridge, MA, November 16, 2020 - Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on its operational progress for the third quarter and nine ...Web

Nasdaq smmt. Things To Know About Nasdaq smmt.

Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After ...WebShares of the clinical-stage biotech Summit Therapeutics ( SMMT 3.76%) are moving northward yet again today. Specifically, the drugmaker's shares were up by a handsome 18.8%, on sky-high volume ...Cambridge, MA, July 12, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying three preeminent ePosters at the prestigious 31st ...WebThe public float for SMMT is 111.75M, and currently, short sellers hold a 9.57% ratio of that floaft. The average trading volume of SMMT on November 08, 2023 was 1.02M shares. SMMT) stock’s latest price update. Summit Therapeutics Inc (NASDAQ: SMMT)’s stock price has plunge by -12.16relation to previous closing price of 2.18.

Cambridge, Massachusetts, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced the postponement of its previously announced ...Web26 de abr. de 2016 ... ... (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ('DMD') and ...

SMMT: SUMMIT THERAPEUTICS INC. veja seus indicadores fundamentalistas, variação ... NASDAQ. PART. S&P 500. PARTICIPAÇÃO NO S&P 500. 0 % arrow_forward. bookmarks ...

Oct 26, 2023 · MENLO PARK, Calif., October 26, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its third quarter 2023 financial results and ... View live Summit Therapeutics Inc. chart to track its stock's price action. Find market predictions, SMMT financials and market news.Simply Wall St. Insider Monkey. Find the latest Summit Therapeutics Inc. (SMMT) stock quote, history, news and other vital information to help you with your stock trading and investing. Oxford, UK, and Cambridge, MA, US, April 30, 2020 - Summit Therapeutics plc (NASDAQ: SMMT) today reports its financial results for the fourth period * and eleven months ended December 31, 2019 ...Nov 25, 2023 · Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting -1.00. At the close of trading, the stock’s price was $2.00, to imply an increase of 2.56% or $0.05 in intraday trading. The SMMT share’s 52-week high ...

Cambridge, MA, October 2, 2020 – Summit (NASDAQ: SMMT) today announces that it has entered into a binding agreement with the Company’s Chief Executive Officer and Executive Chairman, ...

Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter.

Aug 20, 2022 · Those following along with Summit Therapeutics Inc. (NASDAQ:SMMT) will no doubt be intrigued by the recent purchase of shares by Robert Duggan, Co-CEO & Executive Chairman of the company, who ... May 5, 2023 · Shares of Summit Therapeutics ( SMMT 4.93%) were up by 61.4% for the week as of late Friday afternoon, according to data provided by S&P Global Market Intelligence. The healthcare stock, which ... OXFORD, UK, Jan. 21, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (LSE:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ...Webull offers SMMT Ent Holdg (SMMT) historical stock prices, in-depth market analysis, NASDAQ: SMMT real-time stock quote data, in-depth charts, free SMMT options chain data, and a fully built financial calendar to help you invest smart.78% of the company is held by a single shareholder (Robert Duggan) Insiders have been buying lately. If you want to know who really controls Summit Therapeutics Inc. ( NASDAQ:SMMT ), then you'll ...WebMENLO PARK, Calif.--(BUSINESS WIRE)-- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that the Company’s Board of Directors has set the record date for the Company’s previously announced rights offering, which will be available to all holders of record of the Company’s common stock, …MENLO PARK, Calif., January 30, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit" or the "Company") today announced that the Company’s Board of Directors has set the record date for the ...Web

Simply Wall St. Insider Monkey. Find the latest Summit Therapeutics Inc. (SMMT) stock quote, history, news and other vital information to help you with your stock trading and investing.Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript May 11, 2023 Operator: Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call.NASDAQ: SMMT. 2.13USD 0.10. At 04/12/2023 11:30. More information SEC Filings. Current report filing. VIEW FILING. Quarterly report pursuant to sections 13 or 15(d) VIEW FILING More information Analyst Coverage Visit …Summit Therapeutics (NASDAQ:SMMT) is a project of Bob Duggan of Pharmacyclics fame. This is what keeps our hopes in the future of this company alive, even though the company keeps changing so much ...MENLO PARK, Calif.--(BUSINESS WIRE)-- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that the Company’s Board of Directors has set the record date for the Company’s previously announced rights offering, which will be available to all holders of record of the Company’s common stock, …

Summit Therapeutics Inc. Common Stock (SMMT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

Dec 4, 2023 · Summit Therapeutics Inc (NASDAQ:SMMT)’s Major holders. Insiders own 29.61% of the company shares, while shares held by institutions stand at 3.27% with a share float percentage of 4.64%. Investors are also buoyed by the number of investors in a company, with Summit Therapeutics Inc having a total of 119 institutions that hold shares in the ... SMMT | January 20, 2023. Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that we have completed the closing of our previously announced definitive agreement with Akeso Inc. (HKEX Code: 9926.HK, “Akeso”) to in-license its breakthrough bispecific antibody, ivonescimab.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...WebThe public float for SMMT is 111.75M, and currently, short sellers hold a 9.57% ratio of that floaft. The average trading volume of SMMT on November 08, 2023 was 1.02M shares. SMMT) stock’s latest price update. Summit Therapeutics Inc (NASDAQ: SMMT)’s stock price has plunge by -12.16relation to previous closing price of 2.18.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...As part of this collaboration deal, Summit Therapeutics paid $500 million upfront (financed via a rights offering) and could be on the hook for another $4.5 billion in future milestone payouts ($1 ...

(NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to announce its third quarter 2023 financial results and provide an operational ...

Oxford, UK, and Cambridge, MA, US, 5 September 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) presented in vivo proof of concept data for its targeted Enterobacteriaceae antibiotics in ...

Find the latest Insider Activity data for Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com.The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97.Summit Therapeutics Inc. Common Stock (SMMT) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript May 11, 2023 Operator: Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call.Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report)’s stock price dropped 3.9% during trading on Friday . The stock traded as low as $1.94 and last traded at $1.95. Approximately 87,078 shares traded hands during trading, a decline of 95% from the average daily volume of 1,810,309 shares. The stock had previously closed at $2.03. […]Summit Therapeutics Inc. Common Stock (SMMT) Nasdaq Listed. DATA AS OF Nov 26, 2021. 0. Add to Watchlist. Add to Portfolio. SMMT SMMT HISTORICAL DATA.Cambridge, MA, March 26, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that the Company’s Board of Directors has approved a rights offering available to all holders of record of ...Cambridge, MA, June 01, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Ankur Dhingra has been appointed as Chief Financial Officer, effective immediately. “We are in a pivotal time for Team Summit as we seek to expand our portfolio of pipeline assets through potential collaborations and …

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...OXFORD, United Kingdom, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...Nasdaq. 14,305.03 +78.81 ... Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have ...Based on analysts offering 12 month price targets for SMMT in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Instagram:https://instagram. laser stockswhat is the value of a 1943 steel wheat pennyapple earingsbest real estate investment companies Cambridge, Massachusetts, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying an important ePoster at IDWeek 2021. grrr stock forecastmoomoo margin interest rate SMMT Summit Therapeutics Inc Form PRE 14A - Other preliminary proxy statements. ... (NASDAQ:SMMT) Historical Stock Chart From Oct 2023 to Nov 2023 Summit Therapeutics (NASDAQ:SMMT)Summit Therapeutics Inc. (SMMT) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 2.1300 +0.1000 (+4.93%) At close: 04:00PM EST 2.0600 -0.07 … high yield savings vs roth ira Nasdaq Listed DATA AS OF Nov 26, 2021 0 Add to Watchlist Add to Portfolio SMMT SMMT HISTORICAL DATA SMMT Historical Data ... Back to SMMT Overview Get up to 10 …Nov 8, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.